a on opportunities for the isle man global market · a perspective on opportunities for the isle of...

Bio Business Conference 11th December 2014

A Perspective on Opportunities for the Isle of Man to Nurture Winners in the

Global Healthcare Market

Dave TaggartPartner, Juniper Consulting Group

Information to Insight


Where does our perspective come from?

Our Project History: Nearly 1,500 consulting projects over 12 years across global markets.

Our Diverse Clients: J&J, Roche, UN, Stryker, Abbott/AbbVie, Philips Healthcare, Gilead, GSK…

Our Range of Services: Business strategy, market research, epidemiology, health economics.

Our Market Knowledge: Extensive operations in US, EU, Japan.


Where does our perspective come from? • 2 of the 32 members of the Junicon team are Manx:

– Steve Young– Dave Taggart

• Junicon has been working informally with the Manx Biomed Cluster since November 2013.

• Our interest is to see the Isle of Man succeed, and realize an opportunity to make a difference in global healthcare.


Observation 1:

• Demographics and age• Affluence and choice• Non‐cyclical• Accelerates with time and

wealth• Some countries are just at

the beginning

As countries get richer, they spend more on health


Observation 2:This clearly can’t go on forever!


Observation 3:We’re already hitting a ‘value crisis’ in healthcare delivery

Macro Trends Changing Demand Unsustainable Practices Limiting Supply

Legacy of rampant inflation in medical costs:• Salaries of clinicians and support

staff• Prices of new technologies• Costs of facilitiesGross inefficiencies in healthcare delivery:• Few economies of scale• Massive duplication of effort• Little standardization• Huge variability in practice

Main payers (national governments) are facing acute fiscal strains

Aging populations

Value crisis in healthcare delivery

• Outcomes, not activities• Prevention, not cure• Population health• Value‐based purchasing

Our success with acute disease means more chronic disease


Observation 4:Meanwhile, our ability to convert scientific understanding to valuable health outcomes has been inconsistent.

Expensive failures

‘Successes’ ‐ that should have done better

Improvements in prognosis, but not outcome

Pharma / Biotech:Alzheimer’s disease

Medical Devices:Mechanical thrombectomyfor ischemic stroke

Diagnostics:Cardiac biomarkers, PSA

Bigdisappointments

Regenerative Medicine:Cell‐based therapies


Is the glass half full or half empty?


It depends!

PAST: Promoting Technology

Surgical products

Me‐too drugs

Diagnostics that don’t change patient management

Healthcare IT – big data and population health

New models of care delivery –lowest cost setting

Avoidable complications

Diseases that drive costs: diabetes, CHF, obesity…

Prediction and prevention

FUTURE:Improving Outcomes

Therapies that make a transformational differencin the real world

Therapies that make a borderline difference in a study

Features and benefits


How can the Isle of Man offer a sustainable competitive advantage?

• A nimble jurisdiction: Flexible, decisive, responsive• Established sources of capital and corporate services• A track record in data hosting & management, high tech manufacturing• A critical mass of innovators already here, or on their way• Friends in the Manx diaspora• A unique, stable population• A healthcare service capable of exploring new care delivery models

MANX STRENGTHS


What kind of biomedical activities WON’T thrive on the Isle of Man?

• High volume, low cost manufacturing of bulky products• Large scale basic science research• Product development that is reliant on medical KOLs• Large scale clinical trials• Supply chain and logistics


What kind of biomedical activities WILL thrive on the Isle of Man?

• Headquartering, ownership and management• Data management and analytics• Information‐based service provision• High end product development and manufacturing• Healthcare fields that have solid science and ethics, but are

‘difficult’ in other jurisdictions• Real world evaluation of products and technologies that

require a change in how care is delivered

Short answer

Longer answer

Anything that wasn’t excluded on the last slide!


Becoming the Innovation Island:

≠


A full glass ahead!


Thank YouDave Taggart

Partner, Juniper Consulting Group

Information to Insight

a on opportunities for the isle man global market · a perspective on opportunities for the isle of...

Documents